OCUL US67576A1007

Report

Delayed Nasdaq - 05/20 04:00:01 pm
3.35	USD		-1.47%

05/11	Berenberg Bank Cuts Price Target on Ocular Therapeutix to $21 From $23, Maintains Buy Rating	MT
05/10	Ocular therapeutix reports first quarter 2022 financial results and business update	AQ
05/10	HC Wainwright Adjusts Price Target on Ocular Therapeutix to $10 From $14, Reiterates Buy Rating	MT

Calendar

Event chart OCULAR THERAPEUTIX, INC.

Upcoming events on OCULAR THERAPEUTIX, INC.

06/16/22 \| 08:30am		Annual General Meeting
08/09/22		Interim 2022 Earnings Release (Projected)
11/09/22		Q3 2022 Earnings Release (Projected)
03/09/23		FY 2022 Earnings Release (Projected)
05/12/23		Q1 2023 Earnings Release (Projected)

Past events on OCULAR THERAPEUTIX, INC.

05/19/22 \| 11:00am		American Society of Gene and Cell Therapy Conference
05/16/22 \| 05:50pm		American Society of Gene and Cell Therapy Conference - Poster No. M-167
05/09/22 \| 04:30pm		Q1 2022 Earnings Call
05/09/22 \| 04:01pm		Q1 2022 Earnings Release
05/03/22 \| 03:00pm		Association for Research in Vision and Ophthalmology Meeting - Safety and Pharmacodynamic Assessment
05/02/22 \| 05:00pm		Association for Research in Vision and Ophthalmology Meeting - Pharmacokinetics of a Hydrogel-based
05/02/22 \| 02:30pm		Association for Research in Vision and Ophthalmology Meeting - Efficacy and Safety of OTX-DED Dexame
05/01/22 \| 05:36pm		Association for Research in Vision and Ophthalmology Meeting - Pharmacokinetics of a Hydrogel-based
05/01/22 \| 02:15pm		Association for Research in Vision and Ophthalmology Meeting - A 6-Month GLP Toxicology Study of a N
05/01/22 \| 02:15pm		Association for Research in Vision and Ophthalmology Meeting - A Safety and Pharmacokinetic Study of

Past dividends on OCULAR THERAPEUTIX, INC.

- No events available -

Annual results

Fiscal Period : December		2017	2018	2019	2020	2021	2022
Sales M $	Released Forecast Spread	1,92 1,97 -2,6%	1,99 1,98 0,56%	4,23 4,55 -7,1%	17,4 23,4 -26%	43,5 45,5 -4,3%	60,4
Operating income (EBITDA) M $	Released Forecast Spread	-60,3 -60,5 0,30%	-56,8 -53,7 -5,8%	-83,3 -83,4 0,12%	-60,1 -62,0 3,1%	-75,6 -77,5 2,4%	-59,4
Operating profit (EBIT) M $	Released Forecast Spread	-61,9 -64,3 3,7%	-59,1 -58,0 -1,9%	-85,8 -84,0 -2,2%	-62,8 -56,3 -12%	-78,0 -77,5 -0,64%	-65,9
Pre-Tax Profit (EBT) M $	Released Forecast Spread	-63,4 -66,0 3,9%	-60,0 -58,6 -2,3%	-86,4 -82,5 -4,7%	-156 -73,5 -112%	-6,55 -21,3 69%	-71,2
Net income M $	Released Forecast Spread	-63,4 -66,0 3,9%	-60,0 -58,6 -2,3%	-86,4 -82,5 -4,7%	-156 -73,5 -112%	-6,55 -21,3 69%	-71,2
EPS $	Released Forecast Spread	-2,20 -2,31 4,9%	-1,57 -1,54 -1,9%	-1,91 -1,77 -8,2%	-2,56 -1,18 -117%	-0,09 -0,27 67%	-0,88
Announcement Date		03/08/2018	03/07/2019	03/12/2020	03/11/2021	02/28/2022	-

Quarterly results

Fiscal Period : December

2021 Q1

2021 Q2

2021 Q3

2021 Q4

2022 Q1

2022 Q2

Sales
M $

Released
Forecast
Spread

7,34
7,85
-6,4%

11,7
11,5
2,2%

12,2
12,5
-2,4%

12,3
14,4
-15%

13,2
14,0
-5,5%

14,4

Operating income
(EBITDA)
M $

Released
Forecast
Spread

-16,5
-15,0
-10%

-19,6
-18,0
-9,0%

-18,9
-23,0
18%

-17,5
-19,0
8,0%

-17,3
-17,6
1,7%

-17,2

Operating profit
(EBIT)
M $

Released
Forecast
Spread

-20,2
-14,5
-39%

-20,2
-16,2
-25%

-19,5
-20,2
3,3%

-18,0
-17,9
-0,66%

-17,8
-17,5
-1,6%

-17,3

Pre-Tax Profit
(EBT)
M $

Released
Forecast
Spread

3,12
-15,2
121%

-8,48
-16,3
48%

2,66
-21,0
113%

-3,85
-18,1
79%

-12,5
-19,3
35%

-19,0

Net income
M $

Released
Forecast
Spread

3,12
-15,2
121%

-8,48
-16,3
48%

2,66
-21,0
113%

-3,85
-18,1
79%

-12,5
-19,3
35%

-19,0

EPS
$

Released
Forecast
Spread

0,04
-0,20
118%

-0,11
-0,20
46%

0,03
-0,27
111%

-0,05
-0,23
78%

-0,16
-0,25
36%

-0,25

Announcement Date

05/05/2021

08/09/2021

11/08/2021

02/28/2022

05/09/2022

Previous year

Next Year

Upcoming sector events for OCULAR THERAPEUTIX, INC.

07/19/22 \| 06:25am		JOHNSON & JOHNSON : Interim 2022 Earnings Release
07/21/22		ROCHE HOLDING AG : Interim 2022 Earnings Release
07/29/22		ABBVIE INC. : Interim 2022 Earnings Release (Projected)
08/02/22		PFIZER INC. : Interim 2022 Earnings Release (Projected)
08/04/22 \| 06:25am		ELI LILLY AND COMPANY : Interim 2022 Earnings Release
10/18/22		JOHNSON & JOHNSON : Q3 2022 Earnings Release
10/18/22		ROCHE HOLDING AG : Q3 2022 Sales and Revenue Release
11/01/22		PFIZER INC. : Q3 2022 Earnings Release (Projected)
11/01/22 \| 05:25am		ELI LILLY AND COMPANY : Q3 2022 Earnings Release
11/04/22		ABBVIE INC. : Q3 2022 Earnings Release (Projected)

More events

Past sector events for OCULAR THERAPEUTIX, INC.

05/03/22 \| 06:45am		PFIZER INC. : Q1 2022 Earnings Release
04/29/22 \| 07:43am		ABBVIE INC. : Q1 2022 Earnings Release
04/28/22 \| 06:25am		ELI LILLY AND COMPANY : Q1 2022 Earnings Release
04/25/22 \| 01:00am		ROCHE HOLDING AG : Q1 2022 Sales and Revenue Release
04/19/22 \| 06:25am		JOHNSON & JOHNSON : Q1 2022 Earnings Release
02/08/22 \| 06:45am		PFIZER INC. : FY 2021 Earnings Release
02/03/22 \| 06:25am		ELI LILLY AND COMPANY : FY 2021 Earnings Release
02/03/22 \| 01:00am		ROCHE HOLDING AG : FY 2021 Earnings Release
02/02/22 \| 07:43am		ABBVIE INC. : FY 2021 Earnings Release
01/25/22 \| 06:25am		JOHNSON & JOHNSON : FY 2021 Earnings Release

More events

Net sales (Year) - Rate of surprise

EPS (Year) - Rate of surprise

Net sales (Quarter) - Rate of surprise

EPS (Quarter) - Rate of surprise